A
Subsidiary of Precisio Biotix
Home
About Us
Corporate Overview
Management Team
Lead Products
Lysins
R&D Pipeline
LysiThru™
R&D Facilities
News
Contact Us
Contact Us
Careers
English
中文
English
News
HOME >>
News
Precisio Biotix Therapeutics Announces Collaboration with Mayo Clinic
2024-03-14
Precisio Biotix Therapeutics Acquires London-Headquartered CC Bio, Adding World-Class Antibacterial Platform and Top Scientists
2024-03-01
Precisio Biotix Therapeutics Expands The US Management Team with The Hiring of Dr. Raymond Schuch
2024-01-23
Phagelux Subsidiary Company Name Change to Lysigen
2021-11-12
Phagelux Staph Lysin Out-licensing Announcement
2021-11-04
LysiThru™ Public Announcement
2021-10-11
本站使用
百度智能门户
搭建
管理登录
English